Sanofi Forecast, price target & analysts
Sanofi Target price 2025 - Analyst rating & recommendation
Sanofi Classifications & Recommendation:
Sanofi Price Target
| Target Price | €117.75 |
| Price | €91.14 |
| Potential |
29.20%
register free of charge
|
| Number of Estimates | 20 |
|
20 Analysts have issued a price target Sanofi 2026 .
The average Sanofi target price is €117.75.
This is
29.20%
register free of charge
€127.00
39.35%
register free of charge
€100.00
9.72%
register free of charge
|
|
| A rating was issued by 23 analysts: 19 Analysts recommend Sanofi to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Sanofi stock has an average upside potential 2026 of
29.20%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion € | 41.08 | 45.93 |
| 8.63% | 11.80% | |
| EBITDA Margin | 31.98% | 30.31% |
| 1.42% | 5.21% | |
| Net Margin | 13.55% | 18.42% |
| 5.17% | 35.95% |
18 Analysts have issued a sales forecast Sanofi 2025 . The average Sanofi sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an Sanofi EBITDA forecast 2025. The average Sanofi EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Sanofi Analysts have issued a net profit forecast 2025. The average Sanofi net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 4.44 | 6.75 |
| 3.02% | 52.03% | |
| P/E | 13.50 | |
| EV/Sales | 2.65 |
10 Analysts have issued a Sanofi forecast for earnings per share. The average Sanofi EPS is
This results in the following potential growth metrics and future valuations:
Current Sanofi Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Apr 06 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| LEERINK PARTNERS |
Locked
➜
Locked
|
Locked | Mar 30 2025 |
| HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Apr 07 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Apr 06 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
LEERINK PARTNERS:
Locked
➜
Locked
|
Mar 30 2025 |
|
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Mar 19 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Mar 13 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
